.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Fish and Richardson
Novartis
Deloitte
Mallinckrodt
Covington
Fuji
AstraZeneca
Chinese Patent Office
McKinsey

Generated: December 12, 2017

DrugPatentWatch Database Preview

Suppliers and packages for tradename: CLORAZEPATE DIPOTASSIUM

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
MylanCLORAZEPATE DIPOTASSIUMclorazepate dipotassiumTABLET;ORAL071858ANDAMylan Pharmaceuticals Inc.0378-0030-01100 TABLET in 1 BOTTLE, PLASTIC (0378-0030-01)
MylanCLORAZEPATE DIPOTASSIUMclorazepate dipotassiumTABLET;ORAL071858ANDAMylan Pharmaceuticals Inc.0378-0030-05500 TABLET in 1 BOTTLE, PLASTIC (0378-0030-05)
MylanCLORAZEPATE DIPOTASSIUMclorazepate dipotassiumTABLET;ORAL071858ANDAMylan Pharmaceuticals Inc.0378-0040-01100 TABLET in 1 BOTTLE, PLASTIC (0378-0040-01)
MylanCLORAZEPATE DIPOTASSIUMclorazepate dipotassiumTABLET;ORAL071858ANDAMylan Pharmaceuticals Inc.0378-0040-05500 TABLET in 1 BOTTLE, PLASTIC (0378-0040-05)
MylanCLORAZEPATE DIPOTASSIUMclorazepate dipotassiumTABLET;ORAL071858ANDAMylan Pharmaceuticals Inc.0378-0070-01100 TABLET in 1 BOTTLE, PLASTIC (0378-0070-01)
MylanCLORAZEPATE DIPOTASSIUMclorazepate dipotassiumTABLET;ORAL071858ANDAPD-Rx Pharmaceuticals, Inc.43063-030-033 TABLET in 1 BOTTLE, PLASTIC (43063-030-03)
MylanCLORAZEPATE DIPOTASSIUMclorazepate dipotassiumTABLET;ORAL071858ANDAPD-Rx Pharmaceuticals, Inc.43063-030-1212 TABLET in 1 BOTTLE, PLASTIC (43063-030-12)
MylanCLORAZEPATE DIPOTASSIUMclorazepate dipotassiumTABLET;ORAL071858ANDAPD-Rx Pharmaceuticals, Inc.43063-030-066 TABLET in 1 BOTTLE, PLASTIC (43063-030-06)
MylanCLORAZEPATE DIPOTASSIUMclorazepate dipotassiumTABLET;ORAL071858ANDAPD-Rx Pharmaceuticals, Inc.43063-030-1010 TABLET in 1 BOTTLE, PLASTIC (43063-030-10)
MylanCLORAZEPATE DIPOTASSIUMclorazepate dipotassiumTABLET;ORAL071858ANDAPD-Rx Pharmaceuticals, Inc.43063-164-1212 TABLET in 1 BOTTLE, PLASTIC (43063-164-12)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Medtronic
Novartis
Harvard Business School
Mallinckrodt
Argus Health
QuintilesIMS
Dow
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot